Heart Disease Trial, Recruiting NCT06075160 Sponsor: Sejong General Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06075160
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a moderate blockage in a coronary artery (estimated at 50–90% narrowing) and whose doctor has decided that a procedure guided by a specific heart pressure measurement (called RFR) is clinically needed
  • People who have chosen to take part in the study on their own free will and have signed a consent form

Who may not be able to join:

  • People whose heart's pumping function is severely reduced (the heart pumps less than 30% of its normal capacity)
  • People who are in cardiogenic shock (when the heart suddenly cannot pump enough blood to meet the body's needs)
  • People where the artery being studied is the one directly responsible for a recent heart attack
  • People where the artery being studied is the only blood supply to another completely blocked artery
  • People who have significant heart valve disease or a disease affecting the heart muscle
  • People whose heart rate or blood pressure is dangerously low at the time of the procedure (heart rate below 50 beats per minute or blood pressure below 90mmHg)
  • People who have previously had bypass surgery (CABG) where the bypass graft to the artery being studied is still working
  • People who are pregnant or breastfeeding
  • People who have other serious non-heart-related health conditions that mean their life expectancy is less than one year, or that may make it difficult to follow the study's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 82-10-6217-9315

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sejong General Hospital
Registry
ClinicalTrials.gov
Start date
27 July 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

A composite of death from any cause, non-fatal myocardial infarction, or unplanned revascularization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov